Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

September 30, 1999

Study Completion Date

September 30, 1999

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

Doxycycline monohydrate

Capsules, 100 mg, fed

DRUG

Monodox

Capsules, 100 mg, fed

DRUG

Doxycycline Monohydrate

Capsules, 100 mg, fasting

Trial Locations (1)

G1V 2K8

Anapharm, Inc., Sainte-Foy

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY